HSP90B1 and neoplasm: In 1986, gp96, an endoplasmic reticulum-residing member of HSP90 (heat shock proteins), was isolated from fibrosarcomas of mice after stimulation with methylcholanthrene A and was found to function as a tumor rejection antigen [17].